Diminazene Aceturate Treatment of Babesia Babesiosis and blood-borne parasites”

Diminazene Aceturate is a trusted injectable antiprotozoal treatment widely used for managing Babesia (babesiosis) and other blood-borne parasitic infections in dogs. Babesiosis is a serious tick-borne disease that attacks red blood cells and can quickly become life-threatening if left untreated.

 

This product is formulated for veterinary use to help control protozoal infections that cause anemia, weakness, fever, lethargy, and loss of appetite. Diminazene Aceturate works by targeting and disrupting the parasites within the bloodstream, supporting faster recovery when used as part of a proper treatment protocol.

 

Commonly used for:

• Babesia (Babesiosis)

• Other susceptible blood-borne protozoal infections

• Supportive parasite control in infected dogs

 

Key features:

• Injectable veterinary solution

• Designed specifically for animal use only

• Widely used in professional veterinary and breeding settings

• Helps reduce parasite load in the bloodstream

• Often used alongside supportive care as directed by a veterinarian

 

Important notes:

• For animal use only – not for human use

• Administration, dosage, and treatment schedule should follow veterinary guidance

• Proper diagnosis is recommended before treatment

• Store in a cool place and protect from direct sunlight

 

This product is intended for knowledgeable breeders and pet professionals who understand injectable veterinary treatments and proper diseaseDosage explanation (general reference)

 

Diminazene Aceturate is typically dosed based on body weight and given as an intramuscular (IM) injection.

 

The most commonly referenced dosage on 7% ready-to-use formulations is:

 

• 5 mg of Diminazene Aceturate per kg of body weight

This is often expressed on packaging as:

• 1 ml per 20 kg (44 lbs) body weight

or

• 5 ml per 100 kg body weight

 

 

---

 

How this translates for dogs (example ranges)

 

These are weight-based reference ranges, not a substitute for veterinary diagnosis:

 

• 10 lb dog (≈4.5 kg): ~0.2–0.25 ml

• 20 lb dog (≈9 kg): ~0.4–0.5 ml

• 40 lb dog (≈18 kg): ~0.9 ml

• 60 lb dog (≈27 kg): ~1.3–1.4 ml

 

Dose is typically given once, with some protocols allowing a repeat dose after 24–72 hours only if advised.

 

 

---

 

Route of administration

 

• Intramuscular injection (IM)

• Inject deep into muscle (commonly thigh or shoulder area)

• Use sterile technique

• Do not inject intravenously unless specifically directed by a licensed veterinarian

 

 

---

 

Important treatment notes

 

• Accurate body weight is critical to avoid overdosing

• Overdosing can increase the risk of neurological side effects

• Supportive care (fluids, vitamins, monitoring anemia) is often used alongside treatment

• Diagnosis of Babesia species may affect overall treatment strategy

• Not all Babesia strains respond equally—some cases require alternative or combination therapy

 

 

---

 

Safety & compliance notes (important)

 

• For animal use only

• Not for human use

• Use only under veterinary guidance

• Follow all label instructions and local regulations

• Store in a cool place, protected from light

 

 management protocols.